Intercept Pharmaceuticals, Inc.
TREATMENT AND PREVENTION OF INTESTINAL INFLAMMATORY DISEASES WITH A BILE ACID DERIVATIVE
Last updated:
Abstract:
The present application relates to methods of treating or preventing an intestinal inflammatory disease or condition (e.g., intestinal ischemia reperfusion injury) in a subject in need thereof, comprising administering a therapeutically effective amount of a compound of the application.
Status:
Application
Type:
Utility
Filling date:
3 Feb 2020
Issue date:
31 Mar 2022